945535-02-4Relevant academic research and scientific papers
ORGANIC COMPOUNDS
-
Page/Page column 35, (2011/04/14)
The present invention provides compounds of the following structure; [in-line-formulae]A-L1-B-C-D[/in-line-formulae] that are useful for treating or preventing conditions or disorders associated with DGAT1 activity in animals, particularly humans.
SELECTIVE ACYLATION OF 4-SUBSTITUTED-1,3-PHENYLENEDIAMINE
-
Page/Page column 3, (2009/09/07)
This invention is directed to a method of selectively acylating a compound of formula (II): (II), wherein: R1 is NO2, —N+R33, trihalomethyl, —CN, —SO3H, —CO2H, —CO2 R
METHOD OF TREATMENT
-
Page/Page column 60, (2008/12/06)
Method of of preventing or treating myocardial ischemia by inhibiting DGAT1 enzyme with a DGAT1 inhibitor compound.
